Aclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company specializing in immuno-inflammatory diseases, has announced its participation in the 2024 Cantor Global Healthcare Conference. The company's management team will engage in a fireside chat on Tuesday, September 17, 2024, at 8:00 AM ET in New York.
Investors and interested parties can access a webcast of the fireside chat through the 'Events' page in the 'Investors' section of Aclaris' website, www.aclaristx.com. The webcast will remain archived on the company's website for a minimum of 30 days, allowing for later viewing.
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), una compagnia biofarmaceutica in fase clinica specializzata in malattie immuno-infiammatorie, ha annunciato la sua partecipazione alla Conferenza Sanitaria Globale Cantor 2024. Il team di gestione dell'azienda parteciperà a una discussione informale martedì 17 settembre 2024, alle 8:00 AM ET a New York.
Gli investitori e le parti interessate possono accedere a un webcast della discussione informale attraverso la pagina 'Eventi' nella sezione 'Investitori' del sito web di Aclaris, www.aclaristx.com. Il webcast rimarrà archiviato sul sito dell'azienda per un minimo di 30 giorni, permettendo una visione successiva.
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), una empresa biofarmacéutica en etapa clínica especializada en enfermedades inmuno-inflamatorias, ha anunciado su participación en la Conferencia de Salud Global Cantor 2024. El equipo directivo de la compañía participará en una charla informal el martes 17 de septiembre de 2024, a las 8:00 AM ET en Nueva York.
Los inversores y partes interesadas pueden acceder a un webcast de la charla informal a través de la página de 'Eventos' en la sección 'Inversores' del sitio web de Aclaris, www.aclaristx.com. El webcast permanecerá archivado en el sitio web de la compañía por un mínimo de 30 días, permitiendo su visualización posterior.
Aclaris Therapeutics, Inc. (NASDAQ: ACRS)는 면역-염증 질환을 전문으로 하는 임상 단계의 생물 제약 회사로, 2024 칸토 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사의 경영팀은 2024년 9월 17일 화요일, 오전 8시 ET에 뉴욕에서 화기애애한 대화에 참여할 예정입니다.
투자자 및 관심 있는 당사자들은 Aclaris 웹사이트의 '투자자' 섹션의 '이벤트' 페이지를 통해 화기애애한 대화의 웹캐스트에 접근할 수 있습니다, www.aclaristx.com. 웹캐스트는 회사 웹사이트에 최소 30일 동안 보관되어 나중에 볼 수 있게 됩니다.
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), une société bio-pharmaceutique en phase clinique spécialisée dans les maladies immuno-inflammatoires, a annoncé sa participation à la Conférence Mondiale de Santé Cantor 2024. L'équipe dirigeante de la société participera à une discussion informelle le mardi 17 septembre 2024, à 8h00 ET à New York.
Les investisseurs et les parties intéressées peuvent accéder à un webinaire de la discussion informelle via la page 'Événements' dans la section 'Investisseurs' du site web d'Aclaris, www.aclaristx.com. Le webinaire restera archivé sur le site de l'entreprise pendant un minimum de 30 jours, permettant une consultation ultérieure.
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), ein biopharmazeutisches Unternehmen in der klinischen Entwicklungsphase, das sich auf immun-entzündliche Erkrankungen spezialisiert hat, hat seine Teilnahme an der 2024 Cantor Global Healthcare Conference bekannt gegeben. Das Management-Team des Unternehmens wird am Dienstag, den 17. September 2024, um 8:00 Uhr ET in New York an einem informellen Gespräch teilnehmen.
Investoren und interessierte Parteien können über die 'Veranstaltungen'-Seite im 'Investoren'-Bereich der Aclaris-Website www.aclaristx.com auf einen Webcast des informellen Gesprächs zugreifen. Der Webcast wird für mindestens 30 Tage im Archiv der Unternehmenswebsite verfügbar sein, sodass er später angesehen werden kann.
- None.
- None.
WAYNE, Pa., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the Aclaris management team will participate in a fireside chat during the 2024 Cantor Global Healthcare Conference on Tuesday, September 17, 2024 at 8:00 AM ET in New York, New York.
A webcast of the fireside chat may be accessed through the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. The webcast will be archived for at least 30 days on the Aclaris website.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.
Aclaris Therapeutics Contact:
investors@aclaristx.com
FAQ
When is Aclaris Therapeutics (ACRS) participating in the 2024 Cantor Global Healthcare Conference?
How can investors access Aclaris Therapeutics' (ACRS) fireside chat at the 2024 Cantor Global Healthcare Conference?
How long will the webcast of Aclaris Therapeutics' (ACRS) fireside chat be available?
What is the focus of Aclaris Therapeutics (ACRS) as a company?
